Oil & Gas Exploration & Production
Compare Stocks
5 / 10Stock Comparison
VIVK vs PESI vs CLNE vs GEVO vs AMTX
Revenue, margins, valuation, and 5-year total return — side by side.
Waste Management
Oil & Gas Refining & Marketing
Chemicals - Specialty
Oil & Gas Refining & Marketing
VIVK vs PESI vs CLNE vs GEVO vs AMTX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Waste Management | Oil & Gas Refining & Marketing | Chemicals - Specialty | Oil & Gas Refining & Marketing |
| Market Cap | $2K | $207M | $507M | $493M | $213M |
| Revenue (TTM) | $104M | $59M | $439M | $174M | $209M |
| Net Income (TTM) | $-110M | $-18M | $-99M | $-11M | $-74M |
| Gross Margin | 21.1% | 4.1% | 11.7% | 23.4% | 3.4% |
| Operating Margin | -22.3% | -26.3% | 7.4% | -4.6% | -13.4% |
| Forward P/E | 64.1x | — | — | — | — |
| Total Debt | $35M | $4M | $99M | $168M | $318M |
| Cash & Equiv. | $265K | $12M | $158M | $1M | $5M |
VIVK vs PESI vs CLNE vs GEVO vs AMTX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Vivakor, Inc. (VIVK) | 100 | 0.0 | -100.0% |
| Perma-Fix Environme… (PESI) | 100 | 199.8 | +99.8% |
| Clean Energy Fuels … (CLNE) | 100 | 110.5 | +10.5% |
| Gevo, Inc. (GEVO) | 100 | 157.4 | +57.4% |
| Aemetis, Inc. (AMTX) | 100 | 390.0 | +290.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VIVK vs PESI vs CLNE vs GEVO vs AMTX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VIVK is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 0 yrs, beta 0.74, yield 100.0%
- Beta 0.74 vs PESI's 1.85
- 100.0% yield; the other 4 pay no meaningful dividend
PESI is the clearest fit if your priority is long-term compounding.
- 178.6% 10Y total return vs AMTX's 31.1%
CLNE is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.19, Low D/E 17.5%, current ratio 2.32x
- Beta 1.19, current ratio 2.32x
GEVO carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs AMTX's -22.3%
- -6.6% margin vs VIVK's -105.6%
- -1.7% ROA vs VIVK's -57.5%, ROIC -2.8% vs -13.1%
AMTX ranks third and is worth considering specifically for momentum.
- +140.0% vs VIVK's -100.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs AMTX's -22.3% | |
| Quality / Margins | -6.6% margin vs VIVK's -105.6% | |
| Stability / Safety | Beta 0.74 vs PESI's 1.85 | |
| Dividends | 100.0% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +140.0% vs VIVK's -100.0% | |
| Efficiency (ROA) | -1.7% ROA vs VIVK's -57.5%, ROIC -2.8% vs -13.1% |
VIVK vs PESI vs CLNE vs GEVO vs AMTX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VIVK vs PESI vs CLNE vs GEVO vs AMTX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GEVO leads in 2 of 6 categories
VIVK leads 1 • PESI leads 1 • CLNE leads 0 • AMTX leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
GEVO leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLNE is the larger business by revenue, generating $439M annually — 7.5x PESI's $59M. GEVO is the more profitable business, keeping -6.6% of every revenue dollar as net income compared to VIVK's -105.6%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $104M | $59M | $439M | $174M | $209M |
| EBITDAEarnings before interest/tax | -$5M | -$14M | $62M | $18M | -$21M |
| Net IncomeAfter-tax profit | -$110M | -$18M | -$99M | -$11M | -$74M |
| Free Cash FlowCash after capex | -$16M | -$14M | $19M | -$35M | -$38M |
| Gross MarginGross profit ÷ Revenue | +21.1% | +4.1% | +11.7% | +23.4% | +3.4% |
| Operating MarginEBIT ÷ Revenue | -22.3% | -26.3% | +7.4% | -4.6% | -13.4% |
| Net MarginNet income ÷ Revenue | -105.6% | -30.1% | -22.7% | -6.6% | -35.4% |
| FCF MarginFCF ÷ Revenue | -15.1% | -23.4% | +4.3% | -19.9% | -18.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -49.6% | -20.1% | +13.3% | +47.5% | +27.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.9% | -110.5% | +90.0% | +3.8% | +29.8% |
Valuation Metrics
VIVK leads this category, winning 2 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, CLNE's 94.6x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2,277 | $207M | $507M | $493M | $213M |
| Enterprise ValueMkt cap + debt − cash | $35M | $200M | $448M | $659M | $526M |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | -14.89x | -2.29x | -14.50x | -2.44x |
| Forward P/EPrice ÷ next-FY EPS est. | 64.14x | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 94.64x | 102.12x | — |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 3.36x | 1.19x | 3.07x | 1.02x |
| Price / BookPrice ÷ Book value/share | 0.00x | 4.11x | 0.90x | 1.01x | — |
| Price / FCFMarket cap ÷ FCF | — | — | 8.47x | — | — |
Profitability & Efficiency
GEVO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GEVO delivers a -2.4% return on equity — every $100 of shareholder capital generates $-2 in annual profit, vs $-143 for VIVK. PESI carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to VIVK's 0.95x. On the Piotroski fundamental quality scale (0–9), VIVK scores 5/9 vs AMTX's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -143.1% | -34.5% | -17.2% | -2.4% | — |
| ROA (TTM)Return on assets | -57.5% | -20.2% | -9.2% | -1.7% | -29.3% |
| ROICReturn on invested capital | -13.1% | -21.7% | -9.4% | -2.8% | -70.3% |
| ROCEReturn on capital employed | -25.9% | -16.7% | -9.4% | -3.1% | -19.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 5 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.95x | 0.09x | 0.18x | 0.36x | — |
| Net DebtTotal debt minus cash | $35M | -$7M | -$59M | $166M | $313M |
| Cash & Equiv.Liquid assets | $265,019 | $12M | $158M | $1M | $5M |
| Total DebtShort + long-term debt | $35M | $4M | $99M | $168M | $318M |
| Interest CoverageEBIT ÷ Interest expense | -3.06x | -42.14x | -1.07x | -0.04x | -0.27x |
Total Returns (Dividends Reinvested)
Evenly matched — PESI and GEVO and AMTX each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PESI five years ago would be worth $14,563 today (with dividends reinvested), compared to $0 for VIVK. Over the past 12 months, AMTX leads with a +140.0% total return vs VIVK's -100.0%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs VIVK's -96.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -99.5% | -8.8% | +6.9% | -1.5% | +96.2% |
| 1-Year ReturnPast 12 months | -100.0% | +26.2% | +44.4% | +88.0% | +140.0% |
| 3-Year ReturnCumulative with dividends | -100.0% | +21.7% | -46.3% | +65.0% | +37.4% |
| 5-Year ReturnCumulative with dividends | -100.0% | +45.6% | -73.8% | -65.2% | -76.1% |
| 10-Year ReturnCumulative with dividends | -100.0% | +178.6% | -26.9% | -98.6% | +31.1% |
| CAGR (3Y)Annualised 3-year return | -96.5% | +6.8% | -18.7% | +18.2% | +11.2% |
Risk & Volatility
Evenly matched — VIVK and AMTX each lead in 1 of 2 comparable metrics.
Risk & Volatility
VIVK is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than PESI's 1.85 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMTX currently trades 82.1% from its 52-week high vs VIVK's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | 1.85x | 1.19x | 1.64x | 1.46x |
| 52-Week HighHighest price in past year | $52000.00 | $16.50 | $3.11 | $2.97 | $3.80 |
| 52-Week LowLowest price in past year | $0.01 | $8.02 | $1.56 | $1.01 | $1.22 |
| % of 52W HighCurrent price vs 52-week peak | +0.0% | +67.7% | +74.3% | +68.4% | +82.1% |
| RSI (14)Momentum oscillator 0–100 | 30.2 | 41.5 | 44.6 | 53.5 | 58.2 |
| Avg Volume (50D)Average daily shares traded | 45K | 164K | 1.3M | 4.5M | 1.8M |
Analyst Outlook
PESI leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: PESI as "Hold", CLNE as "Buy", GEVO as "Buy", AMTX as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -43.9% for AMTX (target: $2). VIVK is the only dividend payer here at 100.00% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $18.00 | $3.50 | $3.50 | $1.75 |
| # AnalystsCovering analysts | — | 1 | 22 | 14 | 7 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | — | — | — |
| Dividend / ShareAnnual DPS | $2805.43 | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.6% | 0.0% | 0.0% |
GEVO leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). VIVK leads in 1 (Valuation Metrics). 2 tied.
VIVK vs PESI vs CLNE vs GEVO vs AMTX: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is VIVK or PESI or CLNE or GEVO or AMTX a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -22. 3% for Aemetis, Inc. (AMTX). Analysts rate Clean Energy Fuels Corp. (CLNE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — VIVK or PESI or CLNE or GEVO or AMTX?
Over the past 5 years, Perma-Fix Environmental Services, Inc.
(PESI) delivered a total return of +45. 6%, compared to -100. 0% for Vivakor, Inc. (VIVK). Over 10 years, the gap is even starker: PESI returned +178. 6% versus VIVK's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — VIVK or PESI or CLNE or GEVO or AMTX?
By beta (market sensitivity over 5 years), Vivakor, Inc.
(VIVK) is the lower-risk stock at 0. 74β versus Perma-Fix Environmental Services, Inc. 's 1. 85β — meaning PESI is approximately 149% more volatile than VIVK relative to the S&P 500. On balance sheet safety, Perma-Fix Environmental Services, Inc. (PESI) carries a lower debt/equity ratio of 9% versus 95% for Vivakor, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — VIVK or PESI or CLNE or GEVO or AMTX?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -22. 3% for Aemetis, Inc. (AMTX). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -173. 0% for Clean Energy Fuels Corp.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — VIVK or PESI or CLNE or GEVO or AMTX?
Gevo, Inc.
(GEVO) is the more profitable company, earning -21. 1% net margin versus -105. 6% for Vivakor, Inc. — meaning it keeps -21. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEVO leads at -11. 7% versus -22. 3% for VIVK. At the gross margin level — before operating expenses — VIVK leads at 36. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is VIVK or PESI or CLNE or GEVO or AMTX more undervalued right now?
Analyst consensus price targets imply the most upside for GEVO: 72.
4% to $3. 50.
07Which pays a better dividend — VIVK or PESI or CLNE or GEVO or AMTX?
In this comparison, VIVK (100.
0% yield) pays a dividend. PESI, CLNE, GEVO, AMTX do not pay a meaningful dividend and should not be held primarily for income.
08Is VIVK or PESI or CLNE or GEVO or AMTX better for a retirement portfolio?
For long-horizon retirement investors, Vivakor, Inc.
(VIVK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 100. 0% yield). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VIVK: -100. 0%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between VIVK and PESI and CLNE and GEVO and AMTX?
These companies operate in different sectors (VIVK (Energy) and PESI (Industrials) and CLNE (Energy) and GEVO (Basic Materials) and AMTX (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VIVK is a small-cap high-growth stock; PESI is a small-cap quality compounder stock; CLNE is a small-cap quality compounder stock; GEVO is a small-cap high-growth stock; AMTX is a small-cap quality compounder stock. VIVK pays a dividend while PESI, CLNE, GEVO, AMTX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.